Evaluation and management of intermediate and high-risk pulmonary embolism

Ramsey Al-Hakim, Ningcheng Li, Stephanie Nonas, Bishoy Zakhary, Brandon Maughan, Ryan Schenning, Khashayar Farsad, John A. Kaufman

Research output: Contribution to journalArticle

Abstract

OBJECTIVE. The evidence regarding pulmonary embolism treatment has greatly advanced over the past 10 years, particularly in patients with right ventricular dysfunction or hemodynamic instability. Treatment options include systemic anticoagulation, systemic thrombolysis, catheter-assisted thrombus removal (mechanical with or without catheter-directed thrombolysis), and surgical embolectomy. CONCLUSION. This article will review the data available for treatment options and summarize the evidence-based guidelines on treatment of intermediate- or high-risk pulmonary embolism.

Original languageEnglish (US)
Pages (from-to)671-678
Number of pages8
JournalAmerican Journal of Roentgenology
Volume214
Issue number3
DOIs
StatePublished - Jan 1 2020

Keywords

  • Catheter-directed thrombolysis
  • Mechanical thrombectomy
  • Pulmonary embolism
  • Thrombolysis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Evaluation and management of intermediate and high-risk pulmonary embolism'. Together they form a unique fingerprint.

  • Cite this

    Al-Hakim, R., Li, N., Nonas, S., Zakhary, B., Maughan, B., Schenning, R., Farsad, K., & Kaufman, J. A. (2020). Evaluation and management of intermediate and high-risk pulmonary embolism. American Journal of Roentgenology, 214(3), 671-678. https://doi.org/10.2214/AJR.19.21861